Cargando…
Challenges of defining a non-inferiority margin: a case study of non-inferiority randomized controlled trials of oral anti-thrombolytic agents for prophylaxis of venous thromboembolic events after orthopedic surgery
Autores principales: | Wangge, Grace, Klungel, Olaf H, Roes, Kit CB, de Boer, Antonius, Hoes, Arno W, Knol, Mirjam J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287747/ http://dx.doi.org/10.1186/1745-6215-12-S1-A32 |
Ejemplares similares
-
Room for Improvement in Conducting and Reporting Non-Inferiority Randomized Controlled Trials on Drugs: A Systematic Review
por: Wangge, Grace, et al.
Publicado: (2010) -
Regulatory Scientific Advice on Non-Inferiority Drug Trials
por: Wangge, Grace, et al.
Publicado: (2013) -
Phase IV non-inferiority trials and additional claims of benefit
por: Bernabe, Rosemarie DLC, et al.
Publicado: (2013) -
Methods of defining the non-inferiority margin in randomized, double-blind controlled trials: a systematic review
por: Althunian, Turki A., et al.
Publicado: (2017) -
Derivation of the non-inferiority margin for the evaluation of direct oral anticoagulants in the treatment of venous thromboembolism
por: Prins, Martin H, et al.
Publicado: (2013)